| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2018-02-17 | MOR106 | atopic dermatitis | 1 | Galapagos (Belgium) MorphoSys (Germany) | Dermatological diseases |
| 2018-02-16 | guselkumab (CNTO 1959) | psoriasis | 3 | Janssen Research & Development, a J&J company (USA - NJ) | Autoimmune diseases - Dermatological diseases |
| 2018-02-15 | Otezla® (apremilast) | ulcerative colitis | 2 | Celgene (USA - NJ) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2018-02-15 | OPRX-106 | ulcerative colitis | 2 | Protalix BioTherapeutics (Israel) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2018-02-15 | set of bacteriophages specifically | inflammatory bowel disease | 1-2a | Intralytix (USA - MA) | Gastrointestinal diseases - Digestive diseases |
| 2018-02-12 | T cells designed to express mbIL15 | preclinical | Ziopharm Oncology (USA - MA) | Cancer - Oncology | |
| 2018-02-12 | Chronocort® (hydrocortisone modified release capsules) | congenital adrenal hyperplasia (CAH) | 3 | Diurnal Limited (UK) | Rare diseases - Endocrine diseases - Hormonal diseases |
| 2018-02-12 | AT342 | Crigler-Najjar Syndrome | 1-2 | Audentes Therapeutics (USA - CA) | Rare diseases - Genetic diseases - Hepatic diseases - Liver diseases |
| 2018-02-09 | tislelizumab (BGB-A317) | advanced solid tumors - urothelial carcinoma (UC) | 1 | BeiGene (China) | Cancer - Oncology |
| 2018-02-08 | Kevetrin® (thioureidobutyronitrile) | ovarian cancer | 2a | Cellceutix (USA - MA) now Innovation Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2018-02-08 | ABO-102 (SC AAV-SGSH) | mucopolysaccharidosis type IIIA (Sanfilippo B syndrome) | 1-2 | Abeona Therapeutics (USA - NY) | Rare diseases - Genetic diseases |
| 2018-02-07 | ABO-101 (AAV NAGLU) | mucopolysaccharidosis type IIIB (MPS IIIB or Sanfilippo syndrome Type B) | 1-2 | Abeona Therapeutics (USA - NY) | Rare diseases |
| 2018-02-06 | AT982 | Pompe disease | preclinical | Audentes Therapeutics (USA - CA) | Rare diseases - Genetic diseases |
| 2018-02-05 | Rolontis™ (eflapegrastim) | chemotherapy-induced neutropenia in patients with breast cancer. | 3 | Spectrum Pharmaceuticals (USA - NV) | Cancer - Oncology - Hematological diseases |
| 2018-01-31 | tislelizumab (BGB-A317) | advanced unresectable or metastatic esophageal squamous cell carcinoma (ESCC) | 3 | BeiGene (China) | Cancer - Oncology |
| 2018-01-24 | Traumakine® - FP-1201 (human recombinant interferon-beta 1a) | acute respiratory distress syndrome (ARDS) | 1 | Faron Pharmaceuticals (Finland) | Lung diseases - Respiratory diseases - Rare diseases |
| 2018-01-24 | LN-145 | head and neck squamous cell carcinoma (HNSCC) | 2 | Lion Biotechnologies (USA - CA), now Iovance Biotherapeutics (USA - CA) | Cancer - Oncology |
| 2018-01-18 | nelotanserin | Lewy Body dementia | 2 | Axovant Sciences (USA - NY) | Neurological diseases - CNS diseases |
| 2018-01-18 | BM32 | grass pollen allergy | 2 | Biomay (Austria) | Allergic diseases |
| 2018-01-16 | AVXS-101 (adeno-associated virus serotype 9 expressing the human Survival Motor Neuron gene) | spinal muscular atrophy (SMA) Type 2 | 1 | Avexis (USA - IL) | Rare diseases - Genetic diseases - Neuromuscular diseases |
